MOLINA HEALTHCARE INC (MOH) Stock Analyst Ratings
USA - NYSE:MOH - US60855R1005 - Common Stock
140.9 USD
-11.16 (-7.34%)
141.09 USD
+0.19 (+0.13%)
ChartMill assigns a Buy % Consensus number of 66% to MOH. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 190.57. This target is 35.25% above the current price.
MOH was analyzed by 24 analysts. The buy percentage consensus is at 66. So analysts seem to be have mildly positive about MOH.
In the previous month the buy percentage consensus was at a similar level.
MOH was analyzed by 24 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-24 | Cantor Fitzgerald | Maintains | Neutral -> Neutral |
| 2025-10-24 | UBS | Maintains | Neutral -> Neutral |
| 2025-10-24 | Barclays | Downgrade | Equal-Weight -> Underweight |
| 2025-10-24 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-10-14 | Goldman Sachs | Initiate | Neutral |
| 2025-10-14 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-07 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-09-05 | Bernstein | Maintains | Outperform -> Outperform |
| 2025-09-04 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-08-26 | Cantor Fitzgerald | Reiterate | Neutral -> Neutral |
| 2025-08-15 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-07-29 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-07-25 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2025-07-25 | UBS | Maintains | Neutral -> Neutral |
| 2025-07-25 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-25 | Truist Securities | Downgrade | Buy -> Hold |
| 2025-07-25 | Baird | Maintains | Neutral -> Neutral |
| 2025-07-23 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-07-16 | Truist Securities | Maintains | Buy -> Buy |
| 2025-07-11 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-07-10 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2025-06-09 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-06-09 | Morgan Stanley | Initiate | Overweight |
| 2025-06-02 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-25 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-22 | Bernstein | Initiate | Outperform |
| 2025-04-15 | Baird | Downgrade | Outperform -> Neutral |
| 2025-04-11 | Truist Securities | Maintains | Buy -> Buy |
| 2025-04-09 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-04-09 | Guggenheim | Initiate | Neutral |
MOLINA HEALTHCARE INC / MOH FAQ
Can you provide the average price target for MOLINA HEALTHCARE INC stock?
24 analysts have analysed MOH and the average price target is 190.57 USD. This implies a price increase of 35.25% is expected in the next year compared to the current price of 140.9.
Can you provide the consensus rating for MOLINA HEALTHCARE INC stock?
The consensus rating for MOLINA HEALTHCARE INC (MOH) is 65.8333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.